approval · primary record
ROPEGINTERFERON ALFA-2B-NJFT
FDA · BLA · 2026-08-28
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-08-28 |
| Brand | BESREMI |
| Sponsor | PHARMAESSENTIA CORP |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:37.104Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ROPEGINTERFERON ALFA-2B-NJFT:2026-08-28
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.